Dr Eve Worrall

Reader in Health Economics

Eve has worked in global health for more than 25 years with a career that spans research, consultancy and management roles in academia, philanthropy and the commercial sector. She has a background in pure economics and a PhD in health economics (LSTM/University of Liverpool, 2001).

She worked as a post-doctoral research fellow in the economics of malaria at the London School of Hygiene and Tropical Medicine, before moving into a senior analyst role at New Philanthropy Capital. Eve then worked as Health Economics and Policy Advisory and Senior Technical Consultant at Liverpool Associates in Tropical Health (LATH, the consulting arm of LSTM) for five years, with an honorary appointment at LSTM, before moving into a senior management role specialising in the management of complex multi-partner research consortium.

She began to return to research activities in 2015, entered LSTMs career (tenure) track scheme in 2020, successfully completing the three-year targets in 20 months. She was promoted to Reader in November 2022.

Eve is an expert in the economic evaluation of public health interventions in low- and middle-income countries. She has led multiple evaluations in malaria, TB, neglected tropical diseases and more recently non-communicable diseases. She takes a health-systems, equity focussed approach to all her work. Eves other interests are in policy analysis and knowledge translation, where she seeks to understand how scientific evidence can best inform health policy and improve outcomes.

Eve chairs the LSTM institutional Athena Swan self-assessment committee and serves on LSTM’s Equity and Inclusion Committee. She successfully led LSTMs institutional Athena Swan application, making LSTM one of only 20 higher education institutes in the UK to hold this level of institutional award. In these roles and through her research, Eve strives to achieve equitable partnerships and to support people to achieve their career goals, with a particular focus on those who are underrepresented in public health.

Collaborations and partnerships

  • Co-Principal Investigator and Health Economics Work Package leader, MULTILINK: Multimorbidity-associated emergency hospital admissions: a screen and link strategy to improve outcomes for high-risk patients in sub-Saharan Africa. NIHR 2021 to 2025 https://multilinknihr.com/
  • Deputy Principal Investigator and Evidence and Policy Work Package co-leader, PIIVeC: Partnership for increasing the impact of vector borne disease control. MRC-GCRF 2017 to 2022 https://www.piivec.org/
  • Co-Investigator, Health Economist STOPMiP-2: Intermittent preventative treatment: a new malaria strategy to prevent adverse birth outcomes in Papua, Indonesia. MRC. 2021 to 2023 https://clinicaltrials.gov/ct2/show/NCT05294406
  • Co-Investigator, Health Economist STREAM: Evaluation of a standard treatment regimen of anti-tuberculosis drugs for patients with MDR-TB. Vital Strategies. 2019 to 2023
  • Co-Investigator, Health Economist Cups or cash for girls 2: Measuring the medium-term impact of school-based interventions as girls transition into adulthood. MRC 2022 to 2024
  • Co-Investigator, Health Economist Economic evaluation of screening and eaves tube (SET) trial. Bill and Melinda Gates Foundation. 2016 to 2022
  • Co-Investigator, Health Economist LIGHT: Leaving no-one behind Gendered pathways to Health for TB. FCDO, 2020 to 2026 https://www.lstmed.ac.uk/light
  • Co-Investigator, Health Economist Spatial Intelligence System for precision larviciding. IVCC, 2019 to 2021
  • Co-Investigator, Health Economist INTEGRATION: Increasing the uptake of IPTp-SP through Seasonal Malaria Chemoprevention channel delivery. EDCTP 2021 to 2024 https://www.integration-iptp-smc.org/
  • Co-Investigator and Supervisor MSc Fellowship, M Phiri Cost-effectiveness of larviciding and house improvements. Wellcome Trust 2017 to 2021
  • Senior Health Economist. COUNTDOWN on Neglected Tropical Diseases, DFID/FCDO. 2015 to 2021 https://countdown.lstmed.ac.uk/
  • Health Economist, IMPALA: International Multidisciplinary Programme to Address Lung Health and TB in Africa. NIH, 2017 to 2021 https://www.lstmed.ac.uk/impala
  • Health Economist, IMPACT: TB finding and treating cases of TB in communities in Nepal and Vietnam. EU 2017 to 2019 https://cordis.europa.eu/project/id/733174
  • Co-Investigator, Health Economist. Affordable scalable transfluthrin emanators for Zika control, PMI/USAID 2016 to 2018
  • Senior Programme Manager, AvecNet: African vector control, New Tools. EU 2011 to 2017 https://cordis.europa.eu/project/id/265660


Health Economics and Financing, Masters in International Public Health, LSTM 2022
Introduction to Health Economics and Financing, Diploma in Tropical Medicine and Hygeine, LSTM, 2020 to date
Microeconomic principles to inform translation through development of Target Product Profiles, Master of Research (MRes) in Global Health: Translational and Quantitative Skills, LSTM/Lancaster. 2017 to 2022
Online learning module in Health Economics and Financing. MSc International Public Health, LSTM 2021 to 2022

Further relevant expertise, professional memberships, awards

Internal Committee Membership:
• LSTM Athena Swan Institutional Self-Assessment Team, Chair (2020 – present)
• LSTM Strategic Safeguarding Committee, member (2018 – 2020)
• LSTM Equal Opportunities Committee, member (2016 – Present)
• LSTM Centre for Health Systems Strengthening, Steering Group Member (2019 – Present)
Research grants governance roles
• 01/06/2021 to 31/05/2025, Management Committee member, MULTILINK:
• 03/02/2020 to 31/01/2024, Internal advisory board member, LIGHT: Leaving no one behind; pathways to health for TB and HIV.
• 01/11/2019 to 30/07/22, Trial Management Group Member, STREAM (ISRCTN78372190)
• 01/10/2017 to 01/12/2021, Management Board member, Partnership for Increasing the Impact of Vector Control (PIIVeC) Research Consortium (GCRF via MRC)
• 01/03/2016 to 01/10/2019, Management Committee member, Malaria in an Insecticide Resistant Africa (MIRA) Collaborative Research Programme (Wellcome Trust)
• 01/01/2011 to 01/06/2016, Management Committee member, African Vector Control: New Tools (AvecNet) Research Consortium (EU FP7)
External citizenship
05/2022 to 10/22 Scientific Panellist, 2022 Annual Scientific Meeting Royal Society of Tropical Medicine and Hygiene
05/2019 to 10/2019 Scientific Panellist and co-chair of Track 6: External factors influencing health
Congress on Tropical Medicine and Hygiene 2019 European Society of Tropical Medicine and Hygiene
2019 to Date Member The Union: International Union Against TB and Lung Disease
2017 to Date Member Pan African Mosquito Control Association (PAMCA)
2016 to Date Member and Scientific Panellist 2018, 2019, 2020, 2021 and 2022 International Health Economics Association (IHEA)
2016 to Date Member Advocacy and Resource Mobilisation Partner Committee, Roll Back Malaria Initiative
2005 to Date Member Vector Control Working Group, Roll Back Malaria Initiative

Selected publications

  • Canelas, T., Thomsen, E., McDermott, D., Sternberg, E., Thomas, M.B, Worrall, E. “Spatial targeting of Screening + Eave tubes (SET), a house-based malaria control intervention, in Côte d’Ivoire: A geostatistical modelling study” PLOS Global Public Health. 1(11), 2021. https://doi.org/10.1371/journal.pgph.0000030

    Efundem Agboraw, Fred Sosu, Laura Dean, Alice Siakeh, Rachael Thomson, Karsor Kollie, Eve Worrall. “Factors Influencing MDA Adherence and CDD Opportunity Costs in Liberia: A Mixed Methods Approach.” Parasites and Vectors, volume 14, Article number: 557 (2021) https://doi.org/10.1186/s13071-021-05058-w

    Yaro, Jean Baptiste, Alfred Tiono, Antoine Sanou, Hyacinthe K Toe, John Bradley, Alphonse Ouedraogo, Z Amidou Ouedraogo, Moussa Guelbeogo, Efundem Agboraw, Eve Worrall, N’Fale Sagnon, Steve Lindsay, Anne L Wilson. 2021. “Risk Factors Associated With House Entry of Malaria Vectors in an Area of Burkina Faso With High, Persistent Malaria Transmission and High Insecticide Resistance.” Malaria Journal 20, 397 (2021). https://doi.org/10.1186/s12936-021-03926-5

    Luan Nguyen Quang Vo, Rachel Jeanette Forse, Andrew James Codlin, Ha Minh Dang, Vinh Van Truong, Lan Huu Nguyen, Hoa Binh Nguyen, Nhung Viet Nguyen, Kristi Sidney-Annerstedt, Knut Lonnroth, S Bertel Squire, Maxine Caws, Eve Worrall, Noemia Teixeira de Siqueira-Filha. “Socio-Protective Effects of Active Case Finding on Catastrophic Costs from Tuberculosis in Ho Chi Minh City, Viet Nam: A Longitudinal Patient Cost Survey.” BMC Health Services Research volume 21, Article number: 1051 (2021). https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-021-0...

    Mphatso Dennis Phiri, Robert S. McCann, Alinune Nathanael Kabaghe, Henk van den Berg, Tumaini Malenga, Steven Gowelo, Tinashe Tizifa, Willem Takken, Michèle van Vugt, Kamija S. Phiri, Dianne J. Terlouw, Eve Worrall. “Cost of Community-Led Larval Source Management and House Improvement for Malaria Control: A Cost Analysis within a Cluster-Randomized Trial in a Rural District in Malawi.” Malaria Journal 2021 20:1 20(1): 1–17. https://malariajournal.biomedcentral.com/articles/10.1186/s12936-021-038...

    Worrall, Eve et al. 2020. “Coverage Outcomes (Effects), Costs, Cost-Effectiveness, and Equity of Two Combinations of Long-Lasting Insecticidal Net (LLIN) Distribution Channels in Kenya: A Two-Arm Study under Operational Conditions.” BMC Public Health 2020 20:1 20(1): 1–16. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-09...

    Laura Rosu, Jason Madan, Eve Worrall, Ewan Tomeny, Bertel Squire, and STREAM Study Health Economic Evaluation Collaborators 2020. “Economic Evaluation Protocol of a Short, All-Oral Bedaquiline-Containing Regimen for the Treatment of Rifampicin-Resistant Tuberculosis from the STREAM Trial.” BMJ Open 10(12): e042390. https://bmjopen.bmj.com/content/10/12/e042390

    Eleanore D Sternberg, Jackie Cook, Ludovic P Ahoua Alou, Serge Brice Assi, Alphonsine A Koffi, Dimi T Doudou, Carine J Aoura, Rosine Z Wolie, Welbeck A Oumbouke, Eve Worrall, Prof Immo Kleinschmidt, Raphael N'Guessan, Prof Matthew B Thomas, PhD. 2021. “Impact and Cost-Effectiveness of a Lethal House Lure against Malaria Transmission in Central Côte d’Ivoire: A Two-Arm, Cluster-Randomised Controlled Trial.” The Lancet 397(10276): 805–15. (September 13, 2021). https://doi.org/10.1016/S0140-6736(21)00250-6